Adrienne Farid

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Adrienne Farid

Century Therapeutics, Inc. reported in an 8-K filed July 7, 2025 that Adrienne Farid was terminated as Chief Development Officer, effective July 31, 2025.

“Adrienne Farid, Ph.D. from her position as the Company's Chief Development Officer, effective July 31, 2025.”

Century Therapeutics, Inc. Form 8-K, filed July 7, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Adrienne Farid's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Century Therapeutics, Inc. (IPSC)
Proxy statement

Start not stated–2025-07-31

Company network

Recorded roles and call appearances connecting this person to public companies.

Century Therapeutics, Inc.

IPSC

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Terminated: Chief Development Officer Century Therapeutics, Inc. (IPSC)
2025-07-31